科伦药业股价连续3天下跌累计跌幅6.65%，嘉合基金旗下1只基金持80万股，浮亏损失208万元

Group 1 - The core viewpoint is that Kelun Pharmaceutical's stock has experienced a decline, with a 6.65% drop over the last three days, closing at 36.49 yuan per share on August 28, with a total market capitalization of 58.313 billion yuan [1] - Kelun Pharmaceutical, established on May 29, 2002, and listed on June 3, 2010, is primarily engaged in the development, production, and sales of large-volume infusion products, with revenue composition as follows: non-infusion products 47.22%, infusion products 40.86%, R&D projects 8.69%, and others 3.24% [1] Group 2 - From the perspective of major fund holdings, Jiahe Fund has one fund heavily invested in Kelun Pharmaceutical, specifically Jiahe Jinpeng Tieli Mixed A (008905), which held 800,000 shares in the second quarter, unchanged from the previous period, representing 4% of the fund's net value [2] - The fund has incurred a floating loss of approximately 328,000 yuan today, with a total floating loss of 2.08 million yuan during the three-day decline [2] - Jiahe Jinpeng Tieli Mixed A was established on April 29, 2020, with a current scale of 305 million yuan, and has achieved a year-to-date return of 11.15%, ranking 5222 out of 8191 in its category [2]